ADENOID CYSTIC CARCINOMA
Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug trial seeks to tame advanced tumors
Disease control TerminatedThis early-stage study tested a new drug called Felmetatug Vedotin, both alone and combined with pembrolizumab, in people with advanced solid tumors that had spread or could not be removed by surgery. The main goal was to find safe dosage levels and understand side effects for ca…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Targeted radiation tested for Tough-to-Treat cancer
Disease control TerminatedThis study aimed to test a targeted radiation treatment called 177Lu-PSMA for people with advanced adenoid cystic carcinoma, a rare salivary gland cancer that has spread or returned. The first part planned to see how the drug traveled in the body in 10 participants. If successful…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC